학술논문
Initial multicenter clinical experience with the first-generation endoscopic guided laser balloon in Japan
Document Type
Original Paper
Author
Goya, Masahiko; Hirao, Kenzo; Aonuma, Kazutaka; Nogami, Akihiko; Yamane, Teiichi; Yamauchi, Yasuteru; Okishige, Kaoru; Yotsukura, Akihiko; Kimura, Masaomi; Naito, Shigeto; Kato, Ritsushi; Nitta, Junichi; Inaba, Osamu; Satomi, Kazuhiro; Morita, Norishige; Kobayashi, Yoshinori; Inden, Yasuya; Yoshida, Yukihiko; Kakita, Ken; Kobori, Atsushi; Kusano, Kengo; Inoue, Koichi; Masuda, Masaharu; Hiroshima, Kenichi; Koyama, Junjiroh; Kumagai, Koichiro; Okumura, Ken
Source
Journal of Interventional Cardiac Electrophysiology: An International Journal of Cardiac Arrhythmias and Rhythm Management. 66(7):1713-1721
Subject
Language
English
ISSN
1572-8595
Abstract
Background: Isolation of the pulmonary veins (PVs) is the golden standard for atrial fibrillation (AF) ablation. To achieve a permanent PV isolation, the endoscopic guided HeartLight laser balloon system was invented. We analyzed the safety and efficacy of this laser balloon system.Methods and results: Three hundred four patients from 21 investigational sites inside Japan were enrolled in this study. One thousand sixty-two out of 1175 PVs (90.4%) were isolated using the HeartLight laser balloon. The isolation rate of the left superior, left inferior, right superior, and right inferior PVs was 87.8%, 91.3%, 91.6%, and 92.1%, respectively. The procedure time, defined as the time from the venous access to taking out the balloon, was 155 ± 39 min. The fluoroscopic time was 44 ± 25 min. The mean follow-up period was 309 ± 125 days. The freedom from AF recurrence at 3 months was 89.0% and at 12 months 82.1%. Adverse events occurred in 22 patients (7.2%) including phrenic nerve injury lasting more than 3 months in 1.6% and strokes in 1.0% of the patients.Conclusions: This initial experience demonstrated that the laser balloon ablation was feasible for PV isolation in Japanese AF patients.